IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management II, LLC

Q3 2019 Holdings

Filed 2019-11-13 | 21 holdings | $49.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)COM04351P101$22.6M234,59146.0%
Axsome Therapeutics Inc(AXSM)COM05464T104$18.1M892,94636.8%
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$8.2M2,874,60216.8%
10X Genomics Inc.(TXG)COM88025U109$90.0K1,786,4310.2%
Biohaven Pharmaceuticals(BHVN)COMG11196105$29.7K712,9030.1%
Shockwave Medical Inc(SWAVUSD)COM82489T104$19.3K646,4270.0%
Obseva SACOMH5861P103$18.8K2,252,4600.0%
Ra PharmaceuticalsCOM74933V108$16.0K677,1640.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$5.1K426,7810.0%
Spero Therapeutics Inc(SPRO)COM84833T103$5.0K474,0150.0%
Constellation Pharmaceuticals(CNST)COM210373106$4.7K726,6770.0%
Kiniksa Pharmaceuticals LtdCOMG5269C101$4.6K540,4610.0%
La Jolla Pharmaceuticals(LJPC)COM503459604$4.6K518,1020.0%
Kalvista Pharmaceuticals(KALV)COM483497103$4.4K376,8890.0%
Tricida Inc(1T7)COM89610F101$3.7K118,8860.0%
Milestone Pharmaceuticals Inc(MIST)COM59935V107$2.8K148,5600.0%
Marinus Pharmaceuticals IncCOM56854Q101$2.3K1,486,6760.0%
Bellerophon Therapeutics(BLPHEUR)COM078771102$2.0K4,149,3780.0%
Radius Health IncCOM750469207$35213,6670.0%
Proteostasis Therapeutics IncCOM74373B109$110130,7330.0%
Prevail Therapeutics IncCOM74140Y101$322,6040.0%